The World Health Organization defines dementia risk reduction as reducing exposure to modifiable risk factors across the whole of life, not just in old age. In the second edition of its guidelines, released on 15 July 2026, WHO sets the ceiling of that opportunity at up to 45% of dementia risk prevented or delayed if those factors are addressed at population level. That 45% figure is the headline, and it is also the most misread number in the document. It describes what a whole population could gain if every modifiable factor were removed everywhere — not a personal guarantee, and not a promise that any one person's choices cut their own odds by nearly half.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What WHO counts as a modifiable risk factor
- The new addition: air pollution
- What changed from the 2019 edition
- What WHO explicitly does not recommend
- Where the evidence runs out
- Who this guidance is actually written for
- Frequently Asked Questions
What WHO counts as a modifiable risk factor
The second edition reviews 19 potentially modifiable risk factors plus multidomain interventions, which combine several changes at once. WHO groups them into three clusters: healthy behaviours, managing medical conditions, and reducing air pollution exposure. The behaviour cluster covers physical activity, diet, cognitive activity, social activity, tobacco cessation, and reducing harmful alcohol use.
The medical cluster covers obesity, diabetes, hypertension, dyslipidaemia — abnormal blood fats, including high cholesterol — and hearing loss. The WHO guidelines on risk reduction of cognitive decline and dementia grade each recommendation using GRADE methodology, a system that rates how certain the underlying evidence is, so a recommendation's existence is not the same as strong proof behind it. "Modifiable" here means something that can in principle be changed, by a person or by a health system. It does not mean the change is easy, nor that changing it late in life carries the same benefit as changing it early.
The new addition: air pollution
For the first time, WHO recommends reducing exposure to air pollution as part of dementia risk-reduction strategy. That is the clearest break from the 2019 first edition, which addressed only individual lifestyle and clinical factors. The shift matters because it moves dementia prevention out of the clinic.
Air quality is not something a patient manages through willpower; it is set by traffic policy, industrial regulation, cooking fuel, and housing. WHO's own framing in its announcement of the new guidelines treats this as a population-level task. For families, the practical reading is narrower but still real: indoor air is the part you control. Ventilation, clean cooking fuel, and avoiding indoor smoke are the levers available at household scale.
What changed from the 2019 edition
Several existing recommendations were revised rather than added. Diet and nutrition, cognitive activity, social activity, and the management of hearing loss, obesity, hypertension and diabetes all carry updated guidance. Hearing loss is the most concrete change for clinicians: health professionals may now offer hearing aids to people with hearing loss as part of a risk-reduction strategy.
That is a conditional recommendation, not a universal prescription, but it gives a hearing aid conversation a place in a dementia-prevention plan. Tobacco moved the furthest. The 2019 edition made no recommendation on tobacco for dementia risk because the evidence was insufficient. WHO now recommends screening and counselling for tobacco cessation in primary care, with particular focus on adults aged roughly 35 to 65 — midlife, where the exposure window appears to matter most.
What WHO explicitly does not recommend
The guidelines are as specific about what to skip as about what to do, which is useful given how much is sold on brain-health claims. WHO does not recommend the following to reduce dementia risk in people without a diagnosed deficiency: WHO also advises against hormone replacement therapy, acetylcholinesterase inhibitors (the drugs used to treat existing Alzheimer's symptoms), metformin, and aspirin when the goal is reducing dementia risk.
None of this says those products are useless for their own indications — a diagnosed deficiency, menopausal symptoms, diabetes, or cardiovascular prevention are separate questions with separate evidence. It says dementia risk reduction is not a reason to start them.
- Vitamin B or vitamin E supplementation
- Omega-3 polyunsaturated fatty acid supplementation
- Multivitamin or multimineral supplementation
Where the evidence runs out
Five newly reviewed factors — sleep, stroke, traumatic brain injury, vision impairment, and HIV — were brought into the evidence review but did not get a dementia-specific recommendation, because the evidence was insufficient. The Alzheimer's Association's response to the updated guidelines notes this distinction. That is the single easiest thing to misreport.
Appearing in the 2026 update is not an endorsement, and "insufficient evidence for a recommendation" is not the same as "no effect." A page that lists sleep among WHO's dementia recommendations has misread the document. It cuts both ways. Treating a stroke, a head injury, or failing vision remains worth doing on its own merits; WHO simply has not found evidence strong enough to make a dementia-specific call.
Who this guidance is actually written for
The guidelines target adults without dementia — both people with normal cognition and people with mild cognitive impairment, a measurable decline that does not yet interfere with daily independence. The audience is health workers, policy-makers and planners, not consumers, which is why the document reads as clinical protocol rather than advice. WHO's framing is a public-health one for a reason of scale.
Its dementia fact sheet counts 57 million people living with dementia in 2021, nearly 10 million new cases a year, and more than 60% of cases in low- and middle-income countries. WHO notes directly that implementation depends on structural and sociocultural factors beyond individual control — air quality, access to primary care, hearing aid affordability, food environments. If you want to act on this personally, the honest version is: take the three or four factors your own doctor can measure (blood pressure, blood sugar, blood lipids, hearing) to your next appointment and ask which ones are currently uncontrolled.
Frequently Asked Questions
Does the 45% figure mean I can cut my own dementia risk nearly in half?
No. WHO presents up to 45% as a population-level upper bound if all modifiable factors were addressed everywhere. It is not an individual guarantee, and no personal plan has been shown to deliver that reduction.
Should I stop taking omega-3 or a multivitamin?
Not necessarily — WHO's position is only that dementia risk reduction is not a valid reason to take them absent a diagnosed deficiency. If you take them for another medical reason, raise it with your prescriber rather than stopping on your own.
Is it too late if I am already over 65?
The guidelines apply to adults without dementia, including those with mild cognitive impairment, so later-life action is in scope. WHO's tobacco cessation recommendation singles out roughly ages 35 to 65, which suggests midlife is where that particular intervention has the clearest evidence behind it.





